1520-6394/asset/olbannerleft.gif?v=1&s=437dfd7be6907bc2789782afe68e506e19fae73a)
1520-6394/asset/olbannerright.gif?v=1&s=5df2fb724388d4331fe5f91b343d2546ccd6aa08)
Research Article
EFFECT OF TRANSDIAGNOSTIC CBT FOR ANXIETY DISORDERS ON COMORBID DIAGNOSES
Article first published online: 4 DEC 2012
DOI: 10.1002/da.22018
© 2012 Wiley Periodicals, Inc.
Additional Information
How to Cite
Norton, P. J., Barrera, T. L., Mathew, A. R., Chamberlain, L. D., Szafranski, D. D., Reddy, R. and Smith, A. H. (2013), EFFECT OF TRANSDIAGNOSTIC CBT FOR ANXIETY DISORDERS ON COMORBID DIAGNOSES. Depress. Anxiety, 30: 168–173. doi: 10.1002/da.22018
Publication History
- Issue published online: 25 JAN 2013
- Article first published online: 4 DEC 2012
- Manuscript Accepted: 6 OCT 2012
- Manuscript Revised: 24 SEP 2012
- Manuscript Received: 3 JUL 2012
Funded by
- NIMH Mentored Research Scientist Development Award. Grant Number: 1K01MH073920
- Abstract
- Article
- References
- Cited By
Keywords:
- anxiety/anxiety disorders;
- CBT/cognitive behavior therapy;
- clinical trials;
- assessment/diagnosis;
- treatment
Objective
The present study examines the effectiveness of a 12-week transdiagnostic cognitive-behavioral group in reducing comorbid diagnoses.
Method
Data from 79 treatment completers (60.8% women; M age = 32.57 years) during three previous trials of transdiagnostic cognitive behavior therapy (CBT) were examined to compare treatment effects between those with and without comorbid diagnoses. Additionally, rates of remission of comorbid diagnoses were compared to published diagnosis-specific CBT trials.
Results
Results indicate that a majority of clients (64.6%) had at least one comorbid disorder and that those with comorbid diagnoses had higher primary diagnosis severity scores than did those without comorbid diagnoses. The presence of a comorbid diagnosis at pretreatment was not associated with differential improvement in primary diagnosis severity following treatment. Two-thirds of completers with comorbid diagnoses at pretreatment (66.7%) no longer met criteria for a clinically severe comorbid diagnosis at posttreatment, a rate higher than that associated with most trials of diagnosis-specific CBT for anxiety disorders used as benchmarks.
Conclusions
These results suggest that transdiagnostic cognitive-behavioral group treatment for anxiety may be associated with greater decreases in comorbidity than traditional diagnosis-specific CBT.